Everyone Healthy Library
Bullous Pemphigoid
Condition / disease reference page from the Everyone Healthy database.
Connected health information
Explore this condition in a clear order
Linked signs and symptoms
8Each sign/symptom opens its own page and links back to related conditions.
Linked drugs / medications
0No linked drugs are listed yet.
Treatments, therapies and supportive options
2Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Medical therapy
1Linked diagnostic tests and investigations
2These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
Biological and test markers
0This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
No biological marker links are listed yet for this condition.
Introduction / full article
Bullous Pemphigoid
Bullous pemphigoid
Bullous pemphigoid (BP) is a chronic blistering skin disease which ranges from mildly itchy welts to severe blisters and infection. A small area of the body can be affected or it can be widespread. BP has been seen at all ages but the usually affected are the elderly individuals.[1] The disease is characterized by the presence of immunoglobulin G (IgG) autoantibodies specific for the hemidesmosomal bullous pemphigoid antigens BP230 (BPAg1) and BP180 (BPAg2).[2]
Epidemiology
Bullous pemphigoid (BP) is uncommon but cases have been reported throughout the world. In Europe, bullous pemphigoid was identified as the most common subepidermal autoimmune blistering disease. Most treated patients have bullous pemphigoid that remits within 1.5-5 years. In 10-25% of patients, mucosa is involved. Men and women are equally affected. The disease primarily affects individuals in the fifth through seventh decades of life, with an average age at onset of 65 years. A rising incidence of infant-onset bullous pemphigoid has been reported.[2]
Causes
The cause is unknown. BP is thought to be related to immune system disorders, certain other diseases, or use of some medications.[3] It has been postulated that IgG immunoglobulins (antibodies) and activated T lymphocytes (white blood cells) attack components of the basement membrane, specifically a protein called BP antigen BP180, or less commonly BP230. Researches show that bullous pemphigoid appears to be more prevalent in patients that have had neurological disease, particularly stroke, dementia and Parkinson disease.[4]
Symptoms
Some people may present with no symptoms, others may have mild redness and irritation. In severe cases, multiple blisters, called bullae are found. [3] Bullae are large blisters (thin-walled sacs filled with clear fluid). Typically the skin in BP is very itchy and large, red welts and hives may emerge before or during the blister formation. The blisters are widespread and are usually found on the areas of the body that flex or move.[1] Other symptoms include itching, rashes, mouth sores and bleeding gums.[3]
Diagnosis
The history of the patient is obtained and physical examination is done with careful assessment of the skin. Confirmation of diagnosis is often made by a skin biopsy of the blister.[4]
Treatment
In mild cases, an antibiotic, usually tetracycline, is given. Niacin may also be prescribed along with the antibiotic. Most patients are treated with corticosteroids. To suppress the immune system, chemotherapy or medicines may be administered.[3]
References:
- http://www.aocd.org/skin/dermatologic_diseases/bullous_pemphigoid.html
- http://emedicine.medscape.com/article/1062391-overview
- http://www.nlm.nih.gov/medlineplus/ency/article/000883.htm
- http://dermnetnz.org/immune/pemphigoid.html